A comparison of bone mineral density changes during treatment with risperidone or aripiprazole in adolescents

Trial Profile

A comparison of bone mineral density changes during treatment with risperidone or aripiprazole in adolescents

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2011

At a glance

  • Drugs Aripiprazole; Risperidone
  • Indications Schizophrenia and disorders with psychotic features
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Aug 2011 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Planned end date changed from 1 Oct 2008 to 1 Oct 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top